Rheumatic Heart Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2022-07-19
Clinical Trial Update: INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Superiority [Phase 3]
Phase 3 trial investigating anticoagulants for rheumatic heart disease was withdrawn.